{"id":"https://openalex.org/W143675741","doi":null,"title":"A new paradigm for the development of anticancer agents from natural products.","display_name":"A new paradigm for the development of anticancer agents from natural products.","alternate_titles":[],"publication_year":2006,"publication_date":"2006-01-01","ids":{"openalex":"https://openalex.org/W143675741","mag":"143675741","pmid":"https://pubmed.ncbi.nlm.nih.gov/16528970","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1693669"},"language":"en","primary_location":{"id":"pmid:16528970","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16528970","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of experimental therapeutics & oncology","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W143675741"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1693669/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049167701","display_name":"Balanehru Subramanian","orcid":"https://orcid.org/0000-0002-7010-1486","observed_orcids":["https://orcid.org/0000-0002-7010-1486"]},"institutions":[{"id":"https://openalex.org/I154057602","display_name":"Henry Ford Health","ror":"https://ror.org/02kwnkm68","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I154057602"]},{"id":"https://openalex.org/I2803043754","display_name":"Henry Ford Hospital","ror":"https://ror.org/0193sb042","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I154057602","https://openalex.org/I2803043754"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Balanehru Subramanian","raw_affiliation_strings":["Henry Ford Health System, Department of Internal Medicine, Division of Hematology and Oncology, Detroit, MI 48202, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Henry Ford Health System, Department of Internal Medicine, Division of Hematology and Oncology, Detroit, MI 48202, USA","institution_ids":["https://openalex.org/I154057602","https://openalex.org/I2803043754"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110061301","display_name":"Alexander Nakeff","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154057602","display_name":"Henry Ford Health","ror":"https://ror.org/02kwnkm68","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I154057602"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexander Nakeff","raw_affiliation_strings":["Henry Ford Health System"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Henry Ford Health System","institution_ids":["https://openalex.org/I154057602"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066975911","display_name":"Karen Tenney","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I185103710","display_name":"University of California, Santa Cruz","ror":"https://ror.org/03s65by71","country_code":"US","type":"education","lineage":["https://openalex.org/I185103710"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karen Tenney","raw_affiliation_strings":["Univ. of California at Santa Cruz#TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ. of California at Santa Cruz#TAB#","institution_ids":["https://openalex.org/I185103710"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049319108","display_name":"Phillip Crews","orcid":"https://orcid.org/0000-0002-9061-9549","observed_orcids":["https://orcid.org/0000-0002-9061-9549"]},"institutions":[{"id":"https://openalex.org/I185103710","display_name":"University of California, Santa Cruz","ror":"https://ror.org/03s65by71","country_code":"US","type":"education","lineage":["https://openalex.org/I185103710"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Phillip Crews","raw_affiliation_strings":["Univ. of California at Santa Cruz#TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ. of California at Santa Cruz#TAB#","institution_ids":["https://openalex.org/I185103710"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069990783","display_name":"A. A. Leslie Gunatilaka","orcid":"https://orcid.org/0000-0001-9663-3600","observed_orcids":["https://orcid.org/0000-0001-9663-3600"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Leslie Gunatilaka","raw_affiliation_strings":["Natural Resources and the Environment, School of"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Natural Resources and the Environment, School of","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113538222","display_name":"Fred A. Valeriote","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I154057602","display_name":"Henry Ford Health","ror":"https://ror.org/02kwnkm68","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I154057602"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fred Valeriote","raw_affiliation_strings":["Henry Ford Health System"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Henry Ford Health System","institution_ids":["https://openalex.org/I154057602"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.7027,"has_fulltext":false,"cited_by_count":42,"citation_normalized_percentile":{"value":0.91695565,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"5","issue":"3","first_page":"195","last_page":"204"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.26829999685287476,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.26829999685287476,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11385","display_name":"Natural product bioactivities and synthesis","score":0.10849999636411667,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.09560000151395798,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anticancer-drug-development","display_name":"anticancer drug development","score":0.8619999885559082},{"id":"https://openalex.org/keywords/natural-products","display_name":"natural products","score":0.9070000052452087},{"id":"https://openalex.org/keywords/clonogenic-assay","display_name":"clonogenic assay","score":0.9079999923706055},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.7699999809265137},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9890000224113464},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7789999842643738},{"id":"https://openalex.org/keywords/salicortin","display_name":"salicortin","score":0.996999979019165}],"concepts":[{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.7327638864517212},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6555031538009644},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6459870934486389},{"id":"https://openalex.org/C117262875","wikidata":"https://www.wikidata.org/wiki/Q5135057","display_name":"Clonogenic assay","level":3,"score":0.5873806476593018},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.543563723564148},{"id":"https://openalex.org/C2776120743","wikidata":"https://www.wikidata.org/wiki/Q3271540","display_name":"Mechanism of action","level":3,"score":0.4659809470176697},{"id":"https://openalex.org/C86380466","wikidata":"https://www.wikidata.org/wiki/Q5308872","display_name":"Drug action","level":3,"score":0.46466362476348877},{"id":"https://openalex.org/C3018146709","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Anticancer drug","level":3,"score":0.4471203088760376},{"id":"https://openalex.org/C3020079912","wikidata":"https://www.wikidata.org/wiki/Q3918988","display_name":"Plasma concentration","level":2,"score":0.43409016728401184},{"id":"https://openalex.org/C89611455","wikidata":"https://www.wikidata.org/wiki/Q6804646","display_name":"Mechanism (biology)","level":2,"score":0.43249404430389404},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4182148873806},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4085053503513336},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.30515557527542114},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.17318862676620483},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.15230515599250793},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.12501874566078186},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0},{"id":"https://openalex.org/C111472728","wikidata":"https://www.wikidata.org/wiki/Q9471","display_name":"Epistemology","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008962","descriptor_name":"Models, Theoretical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D010600","descriptor_name":"Pharmacology","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":true},{"descriptor_ui":"D040901","descriptor_name":"Proteomics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"pmid:16528970","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16528970","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of experimental therapeutics & oncology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1693669","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1693669/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"J Exp Ther Oncol","raw_type":"Text"},{"id":"mag:143675741","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16528970","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:1693669","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1693669/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"J Exp Ther Oncol","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[{"id":"https://openalex.org/G8396967568","display_name":"Merging Marine-Derived Cytotoxic Natural Products With Experimental Therapeutics","funder_award_id":"R01CA047135","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G962494124","display_name":"Discovery/Development of Anticancer Agents from Plants","funder_award_id":"R01CA092143","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W31323867","https://openalex.org/W43298392","https://openalex.org/W171199456","https://openalex.org/W200269210","https://openalex.org/W347747586","https://openalex.org/W656376022","https://openalex.org/W1977202605","https://openalex.org/W1979313821","https://openalex.org/W1985529943","https://openalex.org/W1987860184","https://openalex.org/W2018327358","https://openalex.org/W2019701027","https://openalex.org/W2022107680","https://openalex.org/W2030486719","https://openalex.org/W2038988557","https://openalex.org/W2048949978","https://openalex.org/W2052767109","https://openalex.org/W2069210297","https://openalex.org/W2081563133","https://openalex.org/W2090377897","https://openalex.org/W2097766883","https://openalex.org/W2103956033","https://openalex.org/W2125380722","https://openalex.org/W2127930924","https://openalex.org/W2162331245","https://openalex.org/W2169705599","https://openalex.org/W2170083676","https://openalex.org/W2213606538","https://openalex.org/W2405735816","https://openalex.org/W2951415217"],"related_works":["https://openalex.org/W1574071220","https://openalex.org/W199853594","https://openalex.org/W2965599057","https://openalex.org/W2321172958","https://openalex.org/W646834581","https://openalex.org/W2989605792","https://openalex.org/W121188475","https://openalex.org/W2784995797","https://openalex.org/W3089490454","https://openalex.org/W2006702541"],"abstract_inverted_index":{"A":[0],"novel":[1],"pharmacology":[2,20],"paradigm":[3],"has":[4],"been":[5,154],"developed":[6],"which":[7,38],"quickly":[8],"and":[9,22,56,68,113,160],"efficiently":[10],"moves":[11],"prospective":[12],"anticancer":[13],"drugs":[14,152],"from":[15],"the":[16,29,40,47,71,75,85,96,99,103,116,121],"discovery":[17],"phase":[18],"through":[19],"testing":[21],"into":[23],"therapeutic":[24,132,141],"trial":[25,133],"assessment.":[26],"Following":[27],"discovery,":[28],"drug":[30,48,72,139],"is":[31,63,134,143],"first":[32,82],"assessed":[33,155],"in":[34,65,110,156],"a":[35,91,130,138,144],"clonogenic":[36],"assay":[37],"determines":[39,102,128],"cytotoxic":[41],"effect":[42],"of":[43,46,120,125,147],"different":[44,51],"concentrations":[45],"at":[49,74,115],"3":[50],"exposure":[52],"durations:":[53],"2h,":[54],"24h":[55],"continuous":[57],"(168":[58],"h).":[59],"Second,":[60],"pharmacokinetic":[61],"information":[62,127],"obtained":[64,109],"both":[66,111],"plasma":[67,112],"tumor":[69,97,114],"for":[70,95],"administered":[73],"maximum":[76,117],"tolerated":[77,118],"dose":[78,119],"given":[79],"intravenously.":[80],"The":[81,123],"study":[83,101,149],"defines":[84],"time-concentration":[86],"profile":[87,105],"required":[88],"to":[89],"obtain":[90],"specific":[92],"cell":[93],"survival":[94],"cells;":[98],"second":[100],"concentration-time":[104],"that":[106],"can":[107],"be":[108],"drug.":[122],"integration":[124],"this":[126,157],"whether":[129],"successful":[131],"possible.":[135],"Only":[136],"when":[137],"shows":[140],"efficacy":[142],"proteomics-based":[145],"mechanism":[146],"action":[148],"initiated.":[150],"Two":[151],"have":[153],"paradigm:":[158],"salicortin":[159],"fascaplysin":[161],"A.":[162]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W143675741","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
